Victrex (LON:VCT) Stock Gets Price Target Increase from Canaccord Genuity Group

Victrex (LON:VCT – Get Free Report) had its price objective lifted by analysts at Canaccord Genuity Group from GBX 725 to GBX 1,050 in a note issued to investors on Tuesday, MarketBeat.com reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 13.76% from the stock’s previous close.

A number of other research analysts have also issued reports on VCT. Berenberg Bank lifted their target price on Victrex from GBX 680 to GBX 870 and gave the stock a “hold” rating in a report on Friday, September 11th. JPMorgan Chase & Co. raised their price objective on shares of Victrex from GBX 625 to GBX 785 and gave the company a “neutral” rating in a research report on Thursday, September 10th. Jefferies Financial Group restated a “hold” rating and issued a GBX 595 price target on shares of Victrex in a research report on Friday, September 25th. Finally, Citigroup boosted their target price on Victrex from GBX 700 to GBX 1,000 and gave the stock a “neutral” rating in a research report on Friday, September 11th. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of GBX 807.86.

View Our Latest Research Report on Victrex

Victrex Stock Up 0.9%

Shares of VCT stock opened at GBX 923 on Tuesday. Victrex has a 1 year low of GBX 515 and a 1 year high of GBX 1,024. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35. The business’s fifty day moving average is GBX 859.03 and its 200-day moving average is GBX 701.79. The stock has a market cap of £804.45 million, a PE ratio of -41.21, a price-to-earnings-growth ratio of 1.92 and a beta of 0.82.

About Victrex

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.

See Also

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.